Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of Pancreatic Fistula After Pancreaticoduodenectomy Using TachoSil
2009-012994-37Phase 3Active
- Sponsor
- Università Campus Bio-Medico di Roma
- Start
- Jun 2009
- Modality
- Recombinant Proteins and Enzymes, Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised trial of tachosil in Postoperative pancreatic fistula (POPF) (2 arms), sponsored by Università Campus Bio-Medico di Roma. Primary endpoint: Amylase value in drain fluid on postoperative day 1 and subsequent days. Started Jun 2009; status: active.
02
Drugs
tachosil
03
Conditions
Postoperative pancreatic fistula (POPF)
Beyond the preview
Go deeper on 2009-012994-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012994-37.